Sub-visible particles (SvPs) are mandatory to be tested in any injectable drug due to their potential risk for patient safety. This applies to the full drug development process and quality control for (global) biologics producers.

Bionter is a Swiss based premier analytical testing supplier, addressing the today's challenges of counting SvPs. Our solution, compared to existing methods, reduces sample size, saves costs, and increases efficiency of the SvPs analysis.